Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based ...

Amy Schumer seems to be feeling herself after losing weight. The comedian — who has admitted to using weight loss drugs to ...

Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as ...

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.

A major international study led by researchers at University College London has found that semaglutide, the active ingredient ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Novo Nordisk faces headwinds from regulatory uncertainty, competitive efficacy gaps with Eli Lilly and technical downward ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

As the name suggests, peptide stacking involves combining multiple amino acid-based supplements to amplify their effects, ...

A groundbreaking study has compared the three top weight loss medications on the market, which has produced some surprising ...